Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Healthcare Medical Devices
Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real... see more

Recent & Breaking News (TSXV:ADK)

DIAGNOS Announces First Screening Project in Poland with Globally Leading Pharmaceutical Company

Marketwired March 18, 2015

Diagnos (V.ADK) inks deal with top American ophthalmology pharmaceutical firm, shares soar 75%

Stockhouse Editorial March 10, 2015

DIAGNOS Announces Contract With a Leading Ophthalmology Pharmaceutical Company in the USA

Marketwired March 10, 2015

DIAGNOS Announces Strategic Restructuring to Focus on Healthcare

Marketwired March 5, 2015

DIAGNOS Announces Pilot With a Major Public Health Institution in Mexico for Retinopathy Screening

Marketwired February 16, 2015

DIAGNOS Opens Polish Subsidiary Diagnos Poland Sp. z o.o.

Marketwired February 12, 2015

DIAGNOS Announces a Screening Program for Vision-Threatening Diseases (VTD) That Will Now Be Offered in Azur Retirement Residences Operated by the Cogir Management Corporation

Marketwired January 21, 2015

Early bird stock picks revealed at Vancouver mining conference

Peter Kennedy January 18, 2015

Alexandria Minerals Corporation Will Use DIAGNOS' CARDS Technology for its Cadillac Break Properties

Marketwired December 11, 2014

DIAGNOS and PUMA Hit Again in the Turgeon South-Bern Zone in New Brunswick, Finding 2% Cu Over 6 Meters

Marketwired December 3, 2014

DIAGNOS Opens Mexican Subsidiary Diagnos Internacional, S.A. de C.V.

Marketwired November 25, 2014

DIAGNOS Announces Resignation to the Board of Directors

Marketwired November 19, 2014

DIAGNOS Announces the Opening of a Clinical Retinopathy Screening Office in Algeria

Marketwired October 16, 2014

DIAGNOS Healthcare's Commercialization of CARA Passes $1M in Bookings

Marketwired October 2, 2014

DIAGNOS Announces Amendment to its Stock Option Plan

Marketwired September 25, 2014

DIAGNOS Announces Contract with Dr. Kovil's Diabetes Care Centre in Mumbai

Marketwired September 16, 2014

DIAGNOS Announces Contract With Dr. Vishal Gupta's Diabetes and Endocrine Clinic in Mumbai

Marketwired September 9, 2014

DIAGNOS Announces Grant of Stock Options

Marketwired September 8, 2014

DIAGNOS Announces First Retinopathy Screening Unit in Turkey

Marketwired September 3, 2014

DIAGNOS Announces First Retinopathy Screening Unit in Eastern Europe

Marketwired August 26, 2014